Forest Laboratories and Nycomed Receive Complete Response Letter for Roflumilast
- Details
- Category: Product

Bayer Schering Pharma Enhances U.S. Research Strategy with New Innovation Center
- Details
- Category: Bayer

Positive pivotal results on escitalopram in Japan
- Details
- Category: Lundbeck

Covex S.A. creates 2000 jobs with the onset of a new agroindustrial project in Latin America
- Details
- Category: Business

Bayer receives approval for its new oral contraceptive in the U.S.
- Details
- Category: Bayer

RA.com Features Interactive Resource to Help People Living with Rheumatoid Arthritis
- Details
- Category: Abbott

New study results on Dulcolax® confirm efficacy and safety
- Details
- Category: Boehringer Ingelheim

More Pharma News ...
- GSK extends presence in Asia with new strategic alliance in South Korea
- Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy
- Abbott licenses 24 Zydus pharmaceutical products for 15 high-growth emerging markets
- GSK Statement on FDA Advisory Committee meeting on Rotavirus vaccines
- EDUCARE (EDUcation for Cancer in African REgions) Project
- Bayer Schering Pharma Initiates Phase III Trial of Regorafenib
- Bayer Schering Pharma Initiates Phase III Trial of Regorafenib (BAY 73-4506)